Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Anthrax Vaccine Nabs Orphan Drug Status

June 16, 2016

A new indication for Emergent BioSolutions’ BioThrax will give the drug market exclusivity through November 2022.

Pfizer Builds Biologics Clinical Manufacturing Facility in Massachusetts

June 16, 2016

Pfizer broke ground at its Andover, Massachusetts campus on a clinical manufacturing facility for complex biologics and vaccines.

FDA Publishes Guidance on Chewable Tablets

June 16, 2016

The agency provides quality, development, manufacturing, and labeling recommendations.

Hovione Breaks Ground on API Facility in New Jersey

June 16, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

Hovione expands drug substance and HPAPI capacity in East Windsor, New Jersey.

Study: Patients Who Have Reactive Responses to Infliximab Should Not Switch to Biosimilar Versions

June 15, 2016

A study published in BMJ indicates that rheumatic patients with anti-infliximab antibodies may have a similar cross reaction to infliximab biosimilars.

FDA Approves Cholera Vaccine

June 13, 2016

FDA approved Vaxchora intended for travelers who are at risk for the disease.

Alvotech Opens mAbs Biosimilar Facility in Iceland

June 10, 2016

Alvotech prepares for commercial biosimilar production in new facility with single-use bioreactors in Reykjavik, Iceland.

GE Healthcare Sells Rights for Inactivated Yellow Fever Vaccine to PnuVax

June 09, 2016

The inactivated vaccine, manufactured with a GE FlexFactory system, could be associated with fewer adverse reactions than the live vaccine option.

Natoli Institute Brings Academic Focus to Industrial Pharmacy

June 08, 2016

Pharmaceutical Technology sat down with Charles N. Kettler, PhD, director of Natoli Scientific, to discuss the Natoli Institute for Industrial Pharmacy at Long Island University.

FDA Reiterates Decision to Require Suffixes in Biosimilar Naming

June 06, 2016

The agency reiterated its earlier decision to require suffixes in biosimilar naming, but was unclear on suffix meaning.